Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Chalfin HJ"'
Autor:
Apolo AB; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Girardi DM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Niglio SA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Nadal R; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Kydd AR; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Simon N; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Ley L; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Cordes LM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Chandran E; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Lee S; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Lee MJ; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Rastogi S; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Sato N; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Cao L; Molecular Targets Core, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Banday AR; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Boudjadi S; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Merino MJ; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Toubaji A; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Akbulut D; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Redd B; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD., Bagheri H; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD., Costello R; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gurram S; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Agarwal PK; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Chalfin HJ; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Valera V; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Streicher H; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Rockville, MD., Wright JJ; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Rockville, MD., Sharon E; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Rockville, MD., Figg WD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Parnes HL; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gulley JL; Center for Onco-Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Saraiya B; Genitourinary Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Pal SK; City of Hope Comprehensive Cancer Center, Duarte, CA., Quinn D; Division of Cancer Medicine and Blood Diseases, Department of Medicine, Genitourinary Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA., Stein MN; Genitourinary Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY., Lara PN; University of California Davis Comprehensive Cancer Center, Sacramento, CA., Bottaro DP; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Mortazavi A; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, and the Comprehensive Cancer Center, Columbus, OH.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 01; Vol. 42 (25), pp. 3033-3046. Date of Electronic Publication: 2024 Jul 02.
Autor:
Chalfin HJ; National Cancer Institute, Bethesda, MD., Yerram N; National Cancer Institute, Bethesda, MD., Owens-Walton J; National Cancer Institute, Bethesda, MD., Gurram S; National Cancer Institute, Bethesda, MD., Li W; National Cancer Institute, Bethesda, MD., Linehan WM; National Cancer Institute, Bethesda, MD., Ball MW; National Cancer Institute, Bethesda, MD. Electronic address: mark.ball@nih.gov.
Publikováno v:
Urologic oncology [Urol Oncol] 2023 May; Vol. 41 (5), pp. 257.e1-257.e6. Date of Electronic Publication: 2023 Apr 08.
Autor:
Girardi DM; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Niglio SA; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Mortazavi A; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, and the Comprehensive Cancer Center, Columbus, Ohio., Nadal R; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Lara P; University of California Davis Comprehensive Cancer Center, Sacramento, California., Pal SK; City of Hope Comprehensive Cancer Center, Duarte, California., Saraiya B; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey., Cordes L; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Ley L; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Ortiz OS; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Cadena J; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Diaz C; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Bagheri H; Clinical Image Processing Service, Department of Radiology and Imaging Sciences, Clinical Center, NIH, Bethesda, Maryland., Redd B; Clinical Image Processing Service, Department of Radiology and Imaging Sciences, Clinical Center, NIH, Bethesda, Maryland., Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Costello R; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Chan KS; Samuel Oschin Cancer Center, Cedars Sinai Medical Center, Los Angeles, California., Lee MJ; Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Lee S; Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Yu Y; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Gurram S; Urologic Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Chalfin HJ; Urologic Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Valera V; Urologic Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Figg WD; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Merino M; Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Toubaji A; Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Streicher H; Investigational Drug Branch, Cancer Therapy Evaluation Program, NCI, NIH, Rockville, Maryland., Wright JJ; Investigational Drug Branch, Cancer Therapy Evaluation Program, NCI, NIH, Rockville, Maryland., Sharon E; Investigational Drug Branch, Cancer Therapy Evaluation Program, NCI, NIH, Rockville, Maryland., Parnes HL; Division of Cancer Prevention, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Ning YM; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Bottaro DP; Urologic Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Cao L; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Trepel JB; Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Apolo AB; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Apr 01; Vol. 28 (7), pp. 1353-1362.
Autor:
Civelek AC; Radiology and Imaging Sciences Department, Nuclear Medicine Division, National Institutes of Health, Bethesda, MD., Niglio SA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Malayeri AA; Radiology and Imaging Sciences Department, Nuclear Medicine Division, National Institutes of Health, Bethesda, MD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Lin J; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gurram S; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Chalfin HJ; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Turkbey B; Radiology and Imaging Sciences Department, Nuclear Medicine Division, National Institutes of Health, Bethesda, MD., Valera V; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, National Cancer Institute, Rockville, MD., Apolo AB; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address: andrea.apolo@nih.gov.
Publikováno v:
Urologic oncology [Urol Oncol] 2021 Nov; Vol. 39 (11), pp. 787.e17-787.e21. Date of Electronic Publication: 2021 Jun 16.
Autor:
Chalfin HJ; The James Buchanan Brady Urological Institute and Greenberg Bladder Cancer Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: heather.chalfin@jhmi.edu., Glavaris SA; The James Buchanan Brady Urological Institute and Greenberg Bladder Cancer Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Gorin MA; The James Buchanan Brady Urological Institute and Greenberg Bladder Cancer Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Kates MR; The James Buchanan Brady Urological Institute and Greenberg Bladder Cancer Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Fong MH; The James Buchanan Brady Urological Institute and Greenberg Bladder Cancer Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Dong L; The James Buchanan Brady Urological Institute and Greenberg Bladder Cancer Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Matoso A; The James Buchanan Brady Urological Institute and Greenberg Bladder Cancer Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Bivalacqua TJ; The James Buchanan Brady Urological Institute and Greenberg Bladder Cancer Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Johnson MH; The James Buchanan Brady Urological Institute and Greenberg Bladder Cancer Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Pienta KJ; The James Buchanan Brady Urological Institute and Greenberg Bladder Cancer Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Hahn NM; The James Buchanan Brady Urological Institute and Greenberg Bladder Cancer Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., McConkey DJ; The James Buchanan Brady Urological Institute and Greenberg Bladder Cancer Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2021 Apr; Vol. 4 (2), pp. 310-314. Date of Electronic Publication: 2019 Sep 26.
Autor:
Chalfin HJ; NCI, Bethesda, Maryland., Pramparo T; Epic Sciences, Inc., San Diego, California., Mortazavi A; Arthur G. James Cancer Hospital, Ohio State University Wexner Medical Center, Columbus, Ohio., Niglio SA; NCI, Bethesda, Maryland., Schonhoft JD; Epic Sciences, Inc., San Diego, California., Jendrisak A; Epic Sciences, Inc., San Diego, California., Chu YL; Epic Sciences, Inc., San Diego, California., Richardson R; Epic Sciences, Inc., San Diego, California., Krupa R; Epic Sciences, Inc., San Diego, California., Anderson AKL; Epic Sciences, Inc., San Diego, California., Wang Y; Epic Sciences, Inc., San Diego, California., Dittamore R; Epic Sciences, Inc., San Diego, California., Pal SK; City of Hope, Duarte, California., Lara PN; University of California, Davis, Sacramento, California., Stein MN; Columbia University, New York, New York., Quinn DI; University of Southern California, Los Angeles, California., Steinberg SM; NCI, Bethesda, Maryland., Cordes LM; NCI, Bethesda, Maryland., Ley L; NCI, Bethesda, Maryland., Mallek M; NCI, Bethesda, Maryland., Sierra Ortiz O; NCI, Bethesda, Maryland., Costello R; NCI, Bethesda, Maryland., Cadena J; NCI, Bethesda, Maryland., Diaz C; NCI, Bethesda, Maryland., Gulley JL; NCI, Bethesda, Maryland., Dahut WL; NCI, Bethesda, Maryland., Streicher H; NCI, Bethesda, Maryland., Wright JJ; NCI, Bethesda, Maryland., Trepel JB; NCI, Bethesda, Maryland., Bottaro DP; NCI, Bethesda, Maryland., Apolo AB; NCI, Bethesda, Maryland. andrea.apolo@nih.gov.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Mar 01; Vol. 27 (5), pp. 1391-1398. Date of Electronic Publication: 2020 Dec 01.
Autor:
Apolo AB; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Nadal R; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Girardi DM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Niglio SA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Ley L; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Cordes LM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Sierra Ortiz O; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Cadena J; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Diaz C; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Mallek M; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Davarpanah NN; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Costello R; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Trepel JB; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Lee MJ; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Merino MJ; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Bagheri MH; Clinical Image Processing Service, Clinical Center, National Institutes of Health, Bethesda, MD., Monk P; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, and the Comprehensive Cancer Center, Columbus, OH., Figg WD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gulley JL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Agarwal PK; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Valera V; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Chalfin HJ; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Jones J; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Streicher H; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Rockville, MD., Wright JJ; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Rockville, MD., Ning YM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Parnes HL; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD., Dahut WL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Bottaro DP; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Lara PN Jr; University of California Davis Comprehensive Cancer Center, Sacramento, CA., Saraiya B; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Pal SK; City of Hope Comprehensive Cancer Center, Duarte, CA., Stein MN; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Mortazavi A; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, and the Comprehensive Cancer Center, Columbus, OH.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Nov 01; Vol. 38 (31), pp. 3672-3684. Date of Electronic Publication: 2020 Sep 11.
Autor:
Chalfin HJ; The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: heather.chalfin@jhmi.edu., Glavaris SA; The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Malihi PD; Bridge Institute, University of Southern California, Los Angeles, California., Sperger JM; Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin., Gorin MA; The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Lu C; The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Goodwin CR; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland., Chen Y; The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Caruso EA; The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Dumpit R; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington., Kuhn P; Bridge Institute, University of Southern California, Los Angeles, California., Lang JM; Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin., Nelson PS; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington., Luo J; The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Pienta KJ; The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Publikováno v:
The Journal of urology [J Urol] 2018 Jun; Vol. 199 (6), pp. 1494-1501. Date of Electronic Publication: 2018 Jan 12.
Autor:
Zarif JC; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine Baltimore, MD 21287., Chalfin HJ; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine Baltimore, MD 21287., Pierorazio PM; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine Baltimore, MD 21287., Gorin MA; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine Baltimore, MD 21287.
Publikováno v:
Journal of clinical urology [J Clin Urol] 2018 May; Vol. 11 (3), pp. 226-228. Date of Electronic Publication: 2017 Jun 16.
Autor:
Chalfin HJ; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: heather.chalfin@jhmi.edu., Kates M; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD., van der Toom EE; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Urology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Glavaris S; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD., Verdone JE; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD., Hahn NM; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD; The Johns Hopkins University Greenberg Bladder Cancer Institute and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD., Pienta KJ; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD., Bivalacqua TJ; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD; The Johns Hopkins University Greenberg Bladder Cancer Institute and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD., Gorin MA; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD.
Publikováno v:
Urology [Urology] 2018 May; Vol. 115, pp. 82-86. Date of Electronic Publication: 2018 Feb 09.